(Q84540462)
Statements
BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer (English)
A Gonçalves
M Gilabert
E François
L Dahan
H Perrier
R Lamy
D Re
R Largillier
M Gasmi
X Tchiknavorian
B Esterni
D Genre
L Moureau-Zabotto
M Giovannini
J-F Seitz
O Turrini